GSK3B and ischemia: Finally, Badimon et al. studied the used a pharmacological approach in order to study the acute effects of GSK3β inhibition with SB415286 and demonstrated a robust reduction in myocardial damage in a mouse model of 60 min ischemia/90 min reperfusion, but no effect following ischemia without reperfusion.